热门资讯> 正文
DiaMedica Therapeutics私募融资3000万美元
2025-07-21 20:27
- DiaMedica Therapeutics (NASDAQ:DMAC) announced on Monday definitive agreements for a $30.1 million private placement of common shares led by current investors.
- Pursuant to the terms of the securities purchase agreements, the company will issue a total of 8.60 million common shares at $3.50 per share.
- The private placement is expected to close on or about July 23, 2025.
- The company said the proceeds would fund its operations for more than two years and support upcoming milestones including the submission of an investigational new drug (IND) application in the United States for preeclampsia and fetal growth restriction and a Phase 2b study to further evaluate DM199 in both indications, pending IND approval.
- Source: Press Release
More on DiaMedica Therapeutics
- DiaMedica gains on positive mid-stage trial data for lead drug in preeclampsia
- DiaMedica Therapeutics to be included in the Russell 2000 and 3000 indexes
- Seeking Alpha’s Quant Rating on DiaMedica Therapeutics
- Historical earnings data for DiaMedica Therapeutics
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
